Results 221 to 227 of about 43,736 (227)

Novel biomarkers for parkinsonian disorders

Parkinsonian disorders (PS) are a heterogeneous group of neurodegenerative diseases characterised by the presence of parkinsonism. Parkinson’s disease (PD) is the most common PS, characterised by the accumulation of alpha-synuclein (αSyn) in Lewy bodies, and the presence of motor features – tremor, bradykinesia, and rigidity.
openaire   +1 more source

Genetic testing for non-parkinsonian movement disorders: Navigating the diagnostic maze

Parkinsonism and Related Disorders
Christine Klein, Cholpon Shambetova
exaly  

Non‐Parkinsonian Movement Disorders

2016
openaire   +1 more source

THE MPTP-INDUCED PARKINSONIAN DISORDER

Behavioural Pharmacology, 1992
openaire   +1 more source

Atypical parkinsonian disorders. Preface.

Seminars in neurology, 2015
Yvette, Bordelon, Carlos, Portera-Cailliau   +1 more
openaire   +1 more source

[Sleep disorders and parkinsonian syndromes].

Revue neurologique, 2011
openaire   +1 more source

Cardiovascular dysfunction in parkinsonian disorders.

Functional neurology, 2002
openaire   +1 more source